Skip to main content
Fig. 1 | International Journal of Bipolar Disorders

Fig. 1

From: Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case–control study of patients with bipolar disorder and healthy control individuals

Fig. 1

Estimates of associations between cerebrospinal fluid levels of amyloid beta-42 and, global cognition and verbal memory, respectively, in patients with bipolar disorder normalized to healthy control standard deviation. The estimates above are “normalized” so that the estimate in the plot resembles the change in the cognitive score when the biomarker increases with one “healthy control” standard deviation

Back to article page